Fluidigm Developing Assay Panels for Gene Expression Studies in Single Stem Cells | GenomeWeb

By Ben Butkus

Fluidigm has developed a new version of its microfluidic Dynamic Array integrated fluidic circuits pre-loaded with a panel of stem cell genes that will allow researchers to conduct PCR-based gene expression studies on single stem cells, company scientists disclosed this week.

Fluidigm is now seeking stem cell researchers with which to collaborate to beta-test and provide feedback on the gene expression panels prior to an anticipated broad product launch later this year, the scientists said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.